Presentation is loading. Please wait.

Presentation is loading. Please wait.

CD8α+, CD8α−, and MoDCs from NOD.hCD205 mice express hCD205.

Published byΠήγασος Αλεξανδρίδης Modified over 5 years ago

Similar presentations

Presentation on theme: "CD8α+, CD8α−, and MoDCs from NOD.hCD205 mice express hCD205."— Presentation transcript:

1 CD8α+, CD8α−, and MoDCs from NOD.hCD205 mice express hCD205.
CD8α+, CD8α−, and MoDCs from NOD.hCD205 mice express hCD205. (A) Expression of hCD205 by splenocytes from C57BL/6 and NOD mice with and without hCD205 (three female mice per group; 15–19 wk old) was analyzed by flow cytometry. (B) hCD205 expression by splenic CD8α+, CD8α−, and MoDCs from C57BL6 (white) and NOD (black) hCD205-transgenic mice. Graph depicts mean MFI + SEM; p values are indicated (t test). Mono, monocytes. Jennifer Schloss et al. ImmunoHorizons 2019;3: Copyright © 2019 The Authors

Download ppt "CD8α+, CD8α−, and MoDCs from NOD.hCD205 mice express hCD205."

Similar presentations

Synergistic antitumor effect of anti-CD40/CpG and 14

Synergistic antitumor effect of anti-CD40/CpG and 14
MR1-TM inhibits the development of severe ATD and pSS in CD28−/− NOD

MR1-TM inhibits the development of severe ATD and pSS in CD28−/− NOD
Volume 6, Issue 5, Pages (November 2009)

Volume 6, Issue 5, Pages (November 2009)
Type 17 immunity is increased in STAT1−/− mice.

Type 17 immunity is increased in STAT1−/− mice.
PD-1 deficiency promotes the development of splenic GCs in male mice, and MR1 dissolves GCs in both genders. PD-1 deficiency promotes the development of.

PD-1 deficiency promotes the development of splenic GCs in male mice, and MR1 dissolves GCs in both genders. PD-1 deficiency promotes the development of.
MP cells are generated from naïve cells in the periphery.

MP cells are generated from naïve cells in the periphery.
Volume 20, Issue 3, Pages (July 2017)

Volume 20, Issue 3, Pages (July 2017)
Viral load and CD4+ T cells in CD8+ T cell–depleted YU-2–infected MISTRG mice. Viral load and CD4+ T cells in CD8+ T cell–depleted YU-2–infected MISTRG.

Viral load and CD4+ T cells in CD8+ T cell–depleted YU-2–infected MISTRG mice. Viral load and CD4+ T cells in CD8+ T cell–depleted YU-2–infected MISTRG.
Depo-Provera altered the expression of cell surface markers associated with HIV susceptibility. Depo-Provera altered the expression of cell surface markers.

Depo-Provera altered the expression of cell surface markers associated with HIV susceptibility. Depo-Provera altered the expression of cell surface markers.
MR1 inhibits anti-MTg autoantibody responses in CD28−/− NOD

MR1 inhibits anti-MTg autoantibody responses in CD28−/− NOD
Changes in splenic CD4+ and CD8+ T cell subsets during acute and chronic HIV infection in MISTRG mice. Changes in splenic CD4+ and CD8+ T cell subsets.

Changes in splenic CD4+ and CD8+ T cell subsets during acute and chronic HIV infection in MISTRG mice. Changes in splenic CD4+ and CD8+ T cell subsets.
Loss of Runx2 in the T cell compartment leads to a defect in the number of CD8+ memory precursor T cells during LCMV–Armstrong infection. Loss of Runx2.

Loss of Runx2 in the T cell compartment leads to a defect in the number of CD8+ memory precursor T cells during LCMV–Armstrong infection. Loss of Runx2.
Smaller T cell zone FRC areas in aged spleens.

Smaller T cell zone FRC areas in aged spleens.
A single DNA vaccination of C57BL/6 mice induced Ab responses of IgG1 and/or IgG2c subclass. A single DNA vaccination of C57BL/6 mice induced Ab responses.

A single DNA vaccination of C57BL/6 mice induced Ab responses of IgG1 and/or IgG2c subclass. A single DNA vaccination of C57BL/6 mice induced Ab responses.
Increased chemokine content and leukocyte infiltrate in D6-negative tumors. Increased chemokine content and leukocyte infiltrate in D6-negative tumors.

Increased chemokine content and leukocyte infiltrate in D6-negative tumors. Increased chemokine content and leukocyte infiltrate in D6-negative tumors.
DKO CD8+ T cells demonstrate a strong effector response but altered memory differentiation and maintenance after LCMV infection. DKO CD8+ T cells demonstrate.

DKO CD8+ T cells demonstrate a strong effector response but altered memory differentiation and maintenance after LCMV infection. DKO CD8+ T cells demonstrate.
VLPs activate DCs and antigen-specific CD8+ T cells via the STING and cGAS pathway. VLPs activate DCs and antigen-specific CD8+ T cells via the STING and.

VLPs activate DCs and antigen-specific CD8+ T cells via the STING and cGAS pathway. VLPs activate DCs and antigen-specific CD8+ T cells via the STING and.
Altered cytokine production by Klrk1−/− NOD CTL

Altered cytokine production by Klrk1−/− NOD CTL
Fig. 3 In situ vaccination with CpG and anti-OX40 is therapeutic in a spontaneous tumor model. In situ vaccination with CpG and anti-OX40 is therapeutic.

Fig. 3 In situ vaccination with CpG and anti-OX40 is therapeutic in a spontaneous tumor model. In situ vaccination with CpG and anti-OX40 is therapeutic.
CD169+ macrophages mediate Lm translocation to the splenic T cell zones. CD169+ macrophages mediate Lm translocation to the splenic T cell zones. (A) Confocal.

CD169+ macrophages mediate Lm translocation to the splenic T cell zones. CD169+ macrophages mediate Lm translocation to the splenic T cell zones. (A) Confocal.

Similar presentations

Ads by Google